Carcinoid syndrome laboratory tests
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome laboratory tests On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome laboratory tests |
|
Risk calculators and risk factors for Carcinoid syndrome laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of carcinoid syndrome include an elevated urinary 5-hydroxyindoleacetic acid (5-HIAA) and plasma levels of Chromogranin A (CgA) levels.[1]
Laboratory Findings
- Laboratory findings consistent with the diagnosis of carcinoid syndrome include an elevated urinary 5-hydroxyindoleacetic acid (5-HIAA) and plasma levels of Chromogranin A (CgA) levels.[1]
- Testing for elevated urinary 5-hydroxyindoleacetic acid (5-HIAA) has a specificity of approximately 88%, although the sensitivity is reported to be as low as 35%.
- Plasma levels of Chromogranin A (CgA) are very sensitive markers of carcinoid syndrome, but not specific as they are also elevated in other types of neuroendocrinal tumors such as pancreatic and small cell lung carcinomas.
- Other biochemical markers associated with carcinoid syndrome include:[1]
References
- ↑ 1.0 1.1 1.2 Diagnostics: Biochemical Markers, Imaging, and Approach. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq